Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

• Jörg Trojan ,

  * E-mail: trojan@em.uni-frankfurt.de

  Affiliation University Hospital, Frankfurt, Germany

  ⨯
• Laurent Mineur,

  Affiliation Institute Sainte Catherine, Avignon, France

  ⨯
• Jiří Tomášek,

  Affiliation Masaryk Memorial Cancer Institute, Brno, Czech Republic

  ⨯
• Etienne Rouleau,

  Affiliation Curie Institute, Paris, France

  ⨯
• Pavel Fabian,

  Affiliation Masaryk Memorial Cancer Institute, Brno, Czech Republic

  ⨯
• Giovanna de Maglio,

  Affiliation University and General Hospital, Udine, Italy

  ⨯
• Pilar García-Alfonso,

  Affiliation Gregorio Marañón Hospital, Madrid, Spain

  ⨯
• Giuseppe Aprile,

  Affiliation University and General Hospital, Udine, Italy

  ⨯
• Aliki Taylor,

  Affiliation Amgen Ltd, Uxbridge, UK

  ⨯
• George Kafatos,

  Affiliation Amgen Ltd, Uxbridge, UK

  ⨯
• Gerald Downey,

  Affiliation Amgen Ltd, Uxbridge, UK

  ⨯
• Jan-Henrik Terwey,

  Affiliation Amgen (Europe) GmbH, Zug Switzerland

  ⨯
• J. Han van Krieken

  Affiliation Radboud University Medical Center, Nijmegen, Netherlands

  ⨯